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Table 2. AFSS scores by SAF classiﬁcation and the correlation between AFSS
outcome scores and SAF classiﬁcation
SAF 0 SAF 1 SAF 2 SAF 3 SAF 4 p value
Correlation
coefﬁcient
(p value)
Total AF burden
(3-30){
5.75.1 9.25.0 15.24.6 17.63.8 21.44.7 < 0.001 0.75
(<0.001)
Symptom
severity
(0-35){
3.34.0 4.25.2 9.94.2 15.25.0 23.6.6.8 <0.001 0.79
(<0.001)
Health care
utilization:
Cardioversion* 0.41.0 0.20.5 0.20.5 0.51.4 0.50.7 0.80 0.08 (0.40)
Emergency
room
visit*
0.30.5 0.51.1 0.61.0 1.31.6 2.51.9 <0.001 0.4
(<0.001)
Hospitalization* 0.30.5 0.50.8 0.50.6 0.71.1 1.41.6 0.08 0.2 (0.05)
Specialist visit* 1.71.5 1.81.8 2.82.6 2.22.1 2.71.7 0.47 0.18 (0.16)
Data are presented as meanstandart deviation. A correlation coeffcient of >0.6
indicates strong correlation. {The numbers indicate range of scores. *The score of the
items in the health care utilization subscale ranges from 0-7. Increasing scores indicate
increasing symptoms. AFSS: Atrial Fibrillation Severity Scale SAF: Severity in Atrial Fibrillation
class
Table 3. Internal consistency of the three domains of the AFSS
Internal consistency (Conbach a)
Total AF burden 0.85
Symptom severity 0.90
Health care utilization 0.67
AFSS: AF severity scale AF: atrial ﬁbrillation
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Table 1. AFSS outcome scores by EHRA classiﬁcation and the correlation
between the AFSS outcome scores and EHRA classiﬁcation
EHRA 1 EHRA 2 EHRA 3 EHRA 4 p value
Correlation
coefﬁcient
(p value)
Total AF burden
(range:3-30)
7.15.2 14.45.3 17.04.6 22.63.4 < 0.001 0.7 (<0.001)
Symptom severity
(range 0-35)
3.64.7 8.85.8 17.76.6 23.87.4 < 0.001 0.7 (<0.001)
Health care
utilization:
Cardioversion (0-7)
*
0.20.6 0.30.84 0.41.2 0.70.8 0.5 0.1 (0.09)
Emergency room
visit
(0-7)*
0.20.4 0.71.1 1.71.8 2.82.0 <0.001 0.4 (<0.001)
Hospitalization (0-
7)*
0.20.4 0.60.8 1.01.1 1.81.6 0.001 0.4 (<0.001)
Specialist visit (0-
7)*
1.51.5 2.52.3 2.52.0 2.81.8 0.2 0.2 (0.07)
Data are presented as meanstandard deviation. *The numbers indicate the range of scores.
A correlation coefﬁcient of > 0.6 indicate strong correlation. Increasing scores indicate
increasing symptoms and severity. AFSS: Atrial Fibrillation Severity Scale EHRA:European
Heart Rhythm Association class
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Objective: This study aimed at the assessment of the clinical approach to AF in
the older population and the consistency with the guidelines based on the records of
the multicenter, prospective AFTER (Atrial Fibrillation in Turkey: Epidemiologic
Registry) study.
Methods: 2242 consecutive patients admitted to the cardiology outpatient clinics of
17 different tertiary health care centers with at least one AF attack determined on
electrocardiographic examination, were included in the study. Among the patients
included in the study, 631 individuals aged 75 years and older were analyzed.
Results: The mean age of the patients was determined as 80.34.2 years. The most
frequent type of AF in geriatric population was the persistent- permanent type with
a percentage of 88%. 60% of the patients with AF were female. Hypertension was the
most common co-morbidity in patients with AF (76%). While in 16% of patients
a history of stroke, transient ischemic attack or systemic thromboembolism was
present, a history of bleeding was present in 14% of the patients. 37% of the patients
were on warfarin treatment and 60% of the patients were on aspirin treatment. In 38 %
of the patients who were on oral anticoagulant treatment, INR level was in the
effective range.
Conclusion: The rate of anticoagulant use in the elderly with AF was 37% and
considering the reason of this situation was the medication not being prescribed by the
physician, one should pay more attention particularly in the ﬁeld of treatment.
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Introduction: Since transition disease has become a reality with the aging of the
population, non-valvular AF appears as a new challenge in the scope of cardiology.
There are two strategies in the treatment of atrial ﬁbrillation. One of them is car-
dioversion and maintenance of sinus rhythm with antiarrhythmic drugs; the other one
is respect of AF and treatment with rate control drugs.
The two strategies were widely compared in the Afﬁrm Study Without superiority
of any of them. However, with a focus on the population studied in Afﬁrm, we notice
that it concerned old population at high risk of Stroke.
The aim of our study is then to compare the two strategies from another angle by
targeting a population of younger and more active patients with AF.
Methods: We randomly assigned, in a prospective open-label study, 266 eligible
patients with non- valvular AF, average age 52,419,6 years, 174 men (65,4 %,sex
ratio 1,89), to undergo a rhythm control (R¼131 patients) or a rate Control (F¼131
pts) strategy.
The average follow -up (FU) was 27,18 months with 4 patients lost of view.
15 pts (8 and 7) were concerned by cross over from one strategy to the other.
Results: 240 pts (90%) pts were symptomatic. AF was paroxystic in 97 pts (36%),
persistent in 61pts (23%) and permanent in 108pts (41%). 203 pts had comorbidities
particularly hypertension in 142 (53%) and diabetes in 34 (13%). Isolated AF was
present in 63pts (24%).219 pts (82%) were at low thromboembolic risk with
a CHADS2 score 1. The hemodynamic status was favorable with an average LVEF
of 64%.
There were fewer events in the R arm than in the F one, appearing late during FU
but the difference wasn't statistically signiﬁcant. There was no signiﬁcant difference in
survival without heart failure or ischemic stroke, respectively 83.8% [CI: 68.5- 100]
and 56.6% [36.4-88], p¼0.43.
Discussion-Conclusion: These results can be explained by the young age of the
population with a low risk in which the events are rare and late in a chronic disease
that requires treatment and long term follow up. For more than 2 years FU, superiority
of rhythm control over rate control wasn't demonstrated despite the patients’ proﬁle
that seemed to be favorable. However, given the shape of the survival curves, we can
anticipate a superiority of rhythm control in the long term.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
